VCM
HCAT icon

Veradace Capital Management’s Health Catalyst HCAT Stock Holding History

Veradace Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Buy
70,000
+20,000
+40% +$28.9K 0.11% 26
2026
Q1 		$63.5K Buy
+50,000
New +$94.1K 0.06% 25

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Veradace Capital Management's HCAT Position: Q2 2026 in Review

Veradace Capital Management increased its Health Catalyst (HCAT) stake by 40% in Q2 2026, buying an estimated $28.9K and bringing the position to 70,000 shares worth $139K. The position accounts for 0.11% of the portfolio, ranked #26.

Veradace Capital Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Veradace Capital Management held 70,000 shares of Health Catalyst worth $139K as of Q2 2026.
  • Veradace Capital Management bought 20,000 Health Catalyst shares in Q2 2026, an estimated $28.9K.
  • Health Catalyst made up 0.11% of Veradace Capital Management's portfolio in Q2 2026, its #26 holding.
  • Veradace Capital Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Veradace Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.